Clinical Trial Update: STI Testing to Enhance PrEP Use in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether STI testing can improve PrEP adherence during pregnancy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Sexually Transmitted Infections

Drugs mentioned

• Emtricitabine/Tenofovir disoproxil fumarate (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Botswana Harvard AIDS Institute Partnership | Conditions: PrEP Adherence, Sexually Transmitted Infections (STIs) | Phase 3 | Status: RECRUITING